Industry Insights

  1. Genetic Therapies Bootcamp Highlights From ACMG 2026 Meeting 6/26/2026

    Review of ACMG 2026 Genetic Therapies Bootcamp, including gene therapy, gene editing, ASOs, rare disease trial design, and the evolving role of genetics professionals.

  2. What Is Patient Payments For Clinical Trials? 6/26/2026

    Late or missing reimbursements push patients out of trials. Real-time, flexible payments help keep them engaged and reduce site workload.

  3. From Buzzword To Backbone: AI Reshaping Clinical Trial Operations 6/26/2026

    For teams evaluating how to accelerate study startup without sacrificing rigor, this is a clear look at what AI-native trial technology makes possible now.

  4. RTSM Automating Adaptive Enrollment In Basket Trials 6/26/2026

    Adaptive basket trials need real-time data to close underperforming cohorts fast. See how automation closes that gap and protects patients.

  5. Clinical Trial Budgeting Faces Pressure To Modernize 6/26/2026

    Outdated budget data slows trial startup. Real-time market benchmarking helps sites and sponsors negotiate faster and get treatments to patients sooner.

  6. Helus Shares Experience Studying Adjunctive Psychedelic For Major Depressive Disorder 6/26/2026

    Helus Pharma CMO Amir Inamdar discusses the strategic rationale behind its Phase 3 trial for major depressive disorder, including its adjunctive-treatment approach, patient population selection, and endpoint strategy.

  7. Understanding And Preserving Data Flow Integrity In AI-Assisted Clinical Trials 6/26/2026

    Learn from ex-FDA and ELIQUENT consultant Dawn Wydner, Ph.D.., how treating data integrity as an end-to-end clinical information flow issue, rather than a database-only concern, is essential to managing AI-related risk.

  8. Electronic Clinical Outcome Assessments (eCOA) In Clinical Trials 6/25/2026

    Manual outcome tracking creates compliance gaps and data quality risks. Electronic assessments help trial teams capture cleaner data, faster.

  9. What Is Interactive Response Technology (IRT)? 6/25/2026

    Learn how protocol-driven IRT systems support supply management and randomization to help trial teams cut risk and costs.

  10. The Psychedelic Setback: What MDMA Rejection Taught Drug Developers 6/25/2026

    Psychedelic compounds show real promise for PTSD, but proving it requires solving unblinding, bias, and safety gaps in trial design.